Recombinant Human ENDOG Protein，His

ENDOG (Endonuclease G) is a mitochondrial enzyme that plays a crucial role in apoptosis and mitochondrial homeostasis. Its involvement in the regulation of cell death processes has attracted considerable interest in the fields of cancer research and neurodegenerative diseases. ENDOG is implicated in the cleavage of mitochondrial DNA, which is essential for cellular energy metabolism and the maintenance of mitochondrial integrity. Additionally, aberrations in ENDOG activity have been linked to various pathological conditions, highlighting its potential as a therapeutic target. Research on recombinant ENDOG proteins aims to elucidate their functional mechanisms and interactions within cellular pathways. By expressing ENDOG in heterologous systems, scientists can study its enzymatic properties, substrate specificity, and effects on apoptosis. Understanding the structure-function relationships of ENDOG can inform the design of small molecule inhibitors or activators, paving the way for novel therapeutic strategies. Furthermore, recombinant ENDOG can be utilized in biochemical assays and high-throughput screening approaches to identify compounds that modulate its activity, thus contributing to the development of targeted treatments for diseases associated with mitochondrial dysfunction. Overall, the study of recombinant ENDOG not only enhances our understanding of fundamental mitochondrial processes but also holds promise for advancing the treatment of diverse diseases characterized by dysregulated apoptosis.